News
Media
Medical World NewsPodcastsVideosInsightsPeer ExchangeMedia DayNews NetworkRoundtables
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Case StudiesWriters and Mentors
Clinical Forum Insights

Subscribe

  • News
  • Media
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Clinical Forum Insights
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Vaccines in America|
Bench to Bedside With SIDP|
Antimicrobial Stewardship|
Hepatitis
Advertisement

VIKTORIJA O. BARR, PHARMD, BCPS-AQ ID

Advertisement

Articles by VIKTORIJA O. BARR, PHARMD, BCPS-AQ ID

Is Greater BSA Use for Sepsis, Bacteremia Affecting HO-CDIs?

ByAlyssa B. Christensen, PHARMD, BCIDP,VIKTORIJA O. BARR, PHARMD, BCPS-AQ ID
November 9th 2017

An examination of broad-spectrum antibiotic use in this patient population is essential for developing strategies to mitigate the risk of these infections.

Advertisement

Latest Updated Articles

  • Is Greater BSA Use for Sepsis, Bacteremia Affecting HO-CDIs?
    Is Greater BSA Use for Sepsis, Bacteremia Affecting HO-CDIs?

    Published: November 9th 2017 | Updated:



Advertisement
Advertisement

Trending on Contagion Live

1

HIV Spending for Fiscal Year 2026: The Latest Update

2

Measles Update: January 30, 2026

3

AAP Releases its Recommended 2026 Childhood and Adolescent Immunization Schedule

4

FDA Clears MicuRx’s IND for MRX-5, Paving the Way for Phase 2a Trial in Hard-to-Treat NTM Lung Disease

5

Systematic Review of Antimicrobial Resistance in Bacterial Meningitis Caused by Streptococcus pneumoniae, Neisseria meningitidis, or Haemophilus influenzae

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us